High dehydroepiandrosterone-sulfate predicts breast cancer progression during new aromatase inhibitor therapy and stimulates breast cancer cell growth in tissue culture: A renewed role for adrenalectomy-Reference-Cited by-同舟云学术

High dehydroepiandrosterone-sulfate predicts breast cancer progression during new aromatase inhibitor therapy and stimulates breast cancer cell growth in tissue culture: A renewed role for adrenalectomy

Published:2001-12 Issue:6 Volume:130 Page:947-953
ISSN:0039-6060
Container-title:Surgery
language:en
Short-container-title:Surgery

Author:

Morris Katherine T.,Toth-Fejel SuEllen,Schmidt Joshua,Fletcher William S.,Pommier Rodney F.

Publisher

Elsevier BV

Subject

Surgery

Reference17 articles.

1. The role of major endocrine ablation;Robin,1977

2. Endocrine therapy of metastatic breast cancer;Henderson,1991

3. Endocrine manipulation in advanced breast cancer;Fletcher,1985

4. Aromatase inhibitors in clinical practice: current status and a look to the future;Harvey;Semin Oncol,1996

5. Aromatase inhibitors and breast cancer;Brodie;Semin Oncol,1996

Cited by 52 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Phase II trial of fulvestrant plus enzalutamide in ER+/HER2− advanced breast cancer;npj Breast Cancer;2023-05-20

2. Quantification of BNN27, a novel neuroprotective 17‐spiroepoxy dehydroepiandrosterone derivative in the blood and retina of rodents, after single intraperitoneal administration;Pharmacology Research & Perspectives;2021-02-27

3. Dehydroepiandrosterone (DHEA);Textbook of Natural Medicine;2020

4. Harnessing a Different Dependency: How to Identify and Target Androgen Receptor-Positive Versus Quadruple-Negative Breast Cancer;Hormones and Cancer;2018-01-16

5. Androgen receptor in estrogen receptor positive breast cancer: Beyond expression;Cancer Treatment Reviews;2017-12